Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Hezhi Fang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0956-3160; OpenAlex author ID A5033069020. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
25
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 3 papers · 2026: 6 papers

Papers 12

  1. Dynamic Alterations of Site-Specific N-Glycoform and Plasma Proteasome Signatures Stratify Chemotherapy Benefit in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1016/j.mcpro.2026.101642↗
  2. Propionyl-CoA catabolism is a metabolic gatekeeper for fatty acid oxidation in pancreatic cancer. Last author DOI 10.1038/s41388-026-03979-3↗
  3. c-Myc/GRPEL1 maintains fatty acid synthesis via FASN to support PDAC cell proliferation. Co-author DOI 10.1038/s41419-026-08439-0↗
  4. Inference of upstream-mutation and metabolomic-signature causality identifies prognostic biomarkers and therapeutic targets in pancreatic cancer. Co-author DOI 10.1038/s41467-026-73871-x↗
  5. 7-Dehydrocholesterol-mediated ferroptosis is governed by glucose availability in pancreatic ductal adenocarcinoma. Co-author DOI 10.3724/abbs.2026106↗
  6. Extracellular Vesicle-Derived Adenosine as a Diagnostic Metabolic Biomarker for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.4143/crt.2025.510↗
  7. β-hydroxybutyrate dehydrogenase promotes pancreatic cancer cell proliferation through regulation of the NAD+/NADH balance and mitochondrial acetylation. Co-author DOI 10.1016/j.jbc.2025.110636↗
  8. The integral membrane protein smim4 modulates redox balance via malate compartmentalization in pancreatic cancer. Last author DOI 10.1038/s41467-025-64734-y↗
  9. The global, regional burden of pancreatic cancer and its attributable risk factors from 1990 to 2021. Last author DOI 10.1186/s12885-025-13471-y↗
  10. YY1 promotes pancreatic cancer cell proliferation by enhancing mitochondrial respiration. Co-author DOI 10.1186/s12935-022-02712-w↗
  11. 4-Hydroxyphenylpyruvate Dioxygenase-Like Protein Promotes Pancreatic Cancer Cell Progression and Is Associated With Glutamine-Mediated Redox Balance. Last author DOI 10.3389/fonc.2020.617190↗
  12. Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth. Co-author DOI 10.1038/s41419-017-0196-z↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wei Cui · 5 shared papers, 2025–2026 · strength 1.27
  2. Jianxin Lyu · 6 shared papers, 2018–2026 · strength 1.16
  3. Shanying Gui · 2 shared papers, 2026 · strength 0.59
  4. Wenhui Ouyang · 2 shared papers, 2026 · strength 0.59
  5. Xiaojun Ren · 2 shared papers, 2026 · strength 0.55
  6. Feng Chen · 2 shared papers, 2026 · strength 0.53
  7. Hongwei Sun · 3 shared papers, 2018–2026 · strength 0.44
  8. Minghua Jiang · 2 shared papers, 2022–2025 · strength 0.36
  9. Xiujuan Wei · 2 shared papers, 2020–2025 · strength 0.34
  10. Tao Xia · 1 shared paper, 2026 · strength 0.32
  11. Yiping Mou · 1 shared paper, 2026 · strength 0.32
  12. Minghua Jiang · 1 shared paper, 2026 · strength 0.28
  13. Jing Wang · 1 shared paper, 2026 · strength 0.28
  14. Tao Huang · 1 shared paper, 2026 · strength 0.28
  15. Weidong Yu · 1 shared paper, 2026 · strength 0.27
  16. Tao Xia · 1 shared paper, 2026 · strength 0.27
  17. Weidong Yu · 1 shared paper, 2025 · strength 0.26
  18. Kai Lin · 1 shared paper, 2026 · strength 0.25
  19. Ruijun Tian · 1 shared paper, 2026 · strength 0.25
  20. Bo Wang · 1 shared paper, 2025 · strength 0.20
  21. Bin Li · 1 shared paper, 2022 · strength 0.16
  22. Xianglai Ye · 1 shared paper, 2020 · strength 0.10
  23. Xujun He · 1 shared paper, 2020 · strength 0.10
  24. Chao Hui ZHOU · 1 shared paper, 2018 · strength 0.07
  25. Jing Gao · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.